Boston Scientific (BSX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Boston Scientific (BSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
Here is how Boston Scientific (BSX) and Novavax (NVAX) have performed compared to their sector so far this year.
Will WATCHMAN Sales Aid Boston Scientific's (BSX) Q2 Earnings?
In EMEA, Boston Scientific (BSX) is expected to have registered growth within structural heart, including Transcatheter aortic valve replacement, WATCHMAN and other interventional cardiology therapies.
Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider
Boston Scientific (BSX) reachead $78.02 at the closing of the latest trading day, reflecting a +0.42% change compared to its last close.
How Does The Current Fall In Abbott Stock Compare With The One During 2008 Recession?
Abbott stock (NYSE: ABT) currently trades at $105 per share, 25% below its peak level of over $140 seen in December 2021. In comparison, its peer Boston Scientific stock (NYSE: BSX) has seen a nearly 90% rise over this period.
Boston Scientific (BSX) Ascends While Market Falls: Some Facts to Note
In the latest trading session, Boston Scientific (BSX) closed at $77.01, marking a +0.01% move from the previous day.
Boston Scientific (BSX) DBS Programming Software Gets CE Mark
Boston Scientific (BSX) secures CE Mark for the DBS image-guided programming software, Vercise Neural Navigator 5.
3 Record-Breaking Stocks With More Room to Run
U.S. markets continued to set all-time highs in June, with record-breaking stocks boosting major indices to new records last week. Even the traditionally slower DJIA logged two consecutive record peaks in two days.
Why Boston Scientific (BSX) Dipped More Than Broader Market Today
Boston Scientific (BSX) closed the most recent trading day at $76.71, moving -1.29% from the previous trading session.
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Boston Scientific (BSX) to Buy Silk Road, Boost Cardiology
This acquisition is expected to enhance Boston Scientific's (BSX) market position and revenue streams in North America and Europe.
4 Medical Product Stocks to Buy From a Recovering Industry
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. BSX, RMD, LNTH and HAE are well-poised to gain from the favorable factors.
